Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay

David N. Chernoff, Richard C. Miner, Bradley S. Hoo, Lu Ping Shen, Reed J. Kelso, Dragana Jekic-McMullen, Jacob P. Lalezari, Sunwen Chou, W. Lawrence Drew, Janice A. Kolberg

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Quantification of cytomegalovirus (CMV) DNA in blood may aid in the identification of patients at highest risk for developing CMV disease, the evaluation of new therapeutics, and the prompt recognition of drug-resistant CMV strains. A branched-DNA (bDNA) assay was developed for the reliable quantification of CMV DNA in peripheral blood leukocytes. The bDNA assay allowed for the highly specific and reproducible quantification of CMV DNA in clinical specimens. Furthermore, the bDNA assay was at least as sensitive as culture techniques and displayed a nearly 3 log10 dynamic range in quantification. Changes in CMV DNA levels measured by the bDNA assay in a human immunodeficiency virus-positive patient undergoing therapy were consistent with CMV culture, antigen, and genotype results and correlated with disease progression and resistance markers. The bDNA assay for the quantification of CMV DNA may provide a useful tool that can be used to aid physicians in monitoring disease progression, evaluating therapeutic regimens, and recognizing viral resistance and drug failure.

Original languageEnglish (US)
Pages (from-to)2740-2744
Number of pages5
JournalJournal of Clinical Microbiology
Volume35
Issue number11
StatePublished - Nov 1997
Externally publishedYes

Fingerprint

Branched DNA Signal Amplification Assay
Cytomegalovirus
Leukocytes
DNA
Disease Progression
Viral Drug Resistance
Culture Techniques
Disease Resistance
Therapeutics
Genotype
HIV
Physicians
Antigens

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Chernoff, D. N., Miner, R. C., Hoo, B. S., Shen, L. P., Kelso, R. J., Jekic-McMullen, D., ... Kolberg, J. A. (1997). Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay. Journal of Clinical Microbiology, 35(11), 2740-2744.

Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay. / Chernoff, David N.; Miner, Richard C.; Hoo, Bradley S.; Shen, Lu Ping; Kelso, Reed J.; Jekic-McMullen, Dragana; Lalezari, Jacob P.; Chou, Sunwen; Drew, W. Lawrence; Kolberg, Janice A.

In: Journal of Clinical Microbiology, Vol. 35, No. 11, 11.1997, p. 2740-2744.

Research output: Contribution to journalArticle

Chernoff, DN, Miner, RC, Hoo, BS, Shen, LP, Kelso, RJ, Jekic-McMullen, D, Lalezari, JP, Chou, S, Drew, WL & Kolberg, JA 1997, 'Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay', Journal of Clinical Microbiology, vol. 35, no. 11, pp. 2740-2744.
Chernoff DN, Miner RC, Hoo BS, Shen LP, Kelso RJ, Jekic-McMullen D et al. Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay. Journal of Clinical Microbiology. 1997 Nov;35(11):2740-2744.
Chernoff, David N. ; Miner, Richard C. ; Hoo, Bradley S. ; Shen, Lu Ping ; Kelso, Reed J. ; Jekic-McMullen, Dragana ; Lalezari, Jacob P. ; Chou, Sunwen ; Drew, W. Lawrence ; Kolberg, Janice A. / Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay. In: Journal of Clinical Microbiology. 1997 ; Vol. 35, No. 11. pp. 2740-2744.
@article{bfd7cc278e7541088a924aea582a237f,
title = "Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay",
abstract = "Quantification of cytomegalovirus (CMV) DNA in blood may aid in the identification of patients at highest risk for developing CMV disease, the evaluation of new therapeutics, and the prompt recognition of drug-resistant CMV strains. A branched-DNA (bDNA) assay was developed for the reliable quantification of CMV DNA in peripheral blood leukocytes. The bDNA assay allowed for the highly specific and reproducible quantification of CMV DNA in clinical specimens. Furthermore, the bDNA assay was at least as sensitive as culture techniques and displayed a nearly 3 log10 dynamic range in quantification. Changes in CMV DNA levels measured by the bDNA assay in a human immunodeficiency virus-positive patient undergoing therapy were consistent with CMV culture, antigen, and genotype results and correlated with disease progression and resistance markers. The bDNA assay for the quantification of CMV DNA may provide a useful tool that can be used to aid physicians in monitoring disease progression, evaluating therapeutic regimens, and recognizing viral resistance and drug failure.",
author = "Chernoff, {David N.} and Miner, {Richard C.} and Hoo, {Bradley S.} and Shen, {Lu Ping} and Kelso, {Reed J.} and Dragana Jekic-McMullen and Lalezari, {Jacob P.} and Sunwen Chou and Drew, {W. Lawrence} and Kolberg, {Janice A.}",
year = "1997",
month = "11",
language = "English (US)",
volume = "35",
pages = "2740--2744",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "11",

}

TY - JOUR

T1 - Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay

AU - Chernoff, David N.

AU - Miner, Richard C.

AU - Hoo, Bradley S.

AU - Shen, Lu Ping

AU - Kelso, Reed J.

AU - Jekic-McMullen, Dragana

AU - Lalezari, Jacob P.

AU - Chou, Sunwen

AU - Drew, W. Lawrence

AU - Kolberg, Janice A.

PY - 1997/11

Y1 - 1997/11

N2 - Quantification of cytomegalovirus (CMV) DNA in blood may aid in the identification of patients at highest risk for developing CMV disease, the evaluation of new therapeutics, and the prompt recognition of drug-resistant CMV strains. A branched-DNA (bDNA) assay was developed for the reliable quantification of CMV DNA in peripheral blood leukocytes. The bDNA assay allowed for the highly specific and reproducible quantification of CMV DNA in clinical specimens. Furthermore, the bDNA assay was at least as sensitive as culture techniques and displayed a nearly 3 log10 dynamic range in quantification. Changes in CMV DNA levels measured by the bDNA assay in a human immunodeficiency virus-positive patient undergoing therapy were consistent with CMV culture, antigen, and genotype results and correlated with disease progression and resistance markers. The bDNA assay for the quantification of CMV DNA may provide a useful tool that can be used to aid physicians in monitoring disease progression, evaluating therapeutic regimens, and recognizing viral resistance and drug failure.

AB - Quantification of cytomegalovirus (CMV) DNA in blood may aid in the identification of patients at highest risk for developing CMV disease, the evaluation of new therapeutics, and the prompt recognition of drug-resistant CMV strains. A branched-DNA (bDNA) assay was developed for the reliable quantification of CMV DNA in peripheral blood leukocytes. The bDNA assay allowed for the highly specific and reproducible quantification of CMV DNA in clinical specimens. Furthermore, the bDNA assay was at least as sensitive as culture techniques and displayed a nearly 3 log10 dynamic range in quantification. Changes in CMV DNA levels measured by the bDNA assay in a human immunodeficiency virus-positive patient undergoing therapy were consistent with CMV culture, antigen, and genotype results and correlated with disease progression and resistance markers. The bDNA assay for the quantification of CMV DNA may provide a useful tool that can be used to aid physicians in monitoring disease progression, evaluating therapeutic regimens, and recognizing viral resistance and drug failure.

UR - http://www.scopus.com/inward/record.url?scp=0030760598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030760598&partnerID=8YFLogxK

M3 - Article

C2 - 9350724

AN - SCOPUS:0030760598

VL - 35

SP - 2740

EP - 2744

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 11

ER -